Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0057 | 0.1183 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0041 | 0.0628 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0041 | 0.0628 | 1 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0057 | 0.1183 | 0.0731 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.0315 | 1 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.0315 | 1 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0041 | 0.0628 | 1 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0037 | 0.0488 | 0.5 |
Loa Loa (eye worm) | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0053 | 0.1052 | 1 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.0315 | 1 | 1 |
Brugia malayi | Inositol-1 | 0.0037 | 0.0488 | 0.412 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0041 | 0.0628 | 1 |
Mycobacterium tuberculosis | Probable short-chain type dehydrogenase/reductase | 0.0057 | 0.1183 | 0.0858 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0315 | 1 | 1 |
Echinococcus multilocularis | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0057 | 0.1183 | 1 |
Trichomonas vaginalis | inositol monophosphatase, putative | 0.0037 | 0.0488 | 0.5 |
Echinococcus granulosus | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0057 | 0.1183 | 1 |
Loa Loa (eye worm) | inositol-1 | 0.0037 | 0.0488 | 0.4635 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.0315 | 1 | 1 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0037 | 0.0488 | 0.5 |
Trypanosoma brucei | inositol-1(or 4)-monophosphatase 1, putative | 0.0037 | 0.0488 | 0.5 |
Mycobacterium leprae | possible inositol monophosphatase SubH (IMPase) (inositol-1-phosphatase) (I-1-Pase ). | 0.0033 | 0.0356 | 0.5 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.0315 | 1 | 0.5 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0037 | 0.0488 | 0.5 |
Leishmania major | 3-oxoacyl-(acyl-carrier protein) reductase, putative | 0.0057 | 0.1183 | 1 |
Toxoplasma gondii | inositol(myo)-1(or 4)-monophosphatase 2, putative | 0.0037 | 0.0488 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0315 | 1 | 1 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0037 | 0.0488 | 0.5 |
Schistosoma mansoni | 3-hydroxyacyl-CoA dehydrogenase | 0.0057 | 0.1183 | 1 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0057 | 0.1183 | 0.0731 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0041 | 0.0628 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 1 ug ml-1 | Minimum inhibitory concentaration against Candida tropicalis ATCC750 evaluated by invtro agar diffusion and microbroth dilution assay | ChEMBL. | 15978808 |
MIC (functional) | = 2 ug ml-1 | Minimum inhibitory concentaration against Candida albicans A261 evaluated by invtro agar diffusion and microbroth dilution assay | ChEMBL. | 15978808 |
MIC (functional) | = 2 ug ml-1 | Minimum inhibitory concentaration against Candida albicans V-01-191 evaluated by invtro agar diffusion and microbroth dilution assay | ChEMBL. | 15978808 |
MIC (functional) | = 2 ug ml-1 | Minimum inhibitory concentaration against Candida parapsilosis ATCC22019 evaluated by invtro agar diffusion and microbroth dilution assay | ChEMBL. | 15978808 |
MIC (functional) | = 2 ug ml-1 | Minimum inhibitory concentaration against Candida glabrata ATCC90030 evaluated by invtro agar diffusion and microbroth dilution assay | ChEMBL. | 15978808 |
MIC (functional) | = 2 ug ml-1 | Minimum inhibitory concentaration against Candida albicans A261 evaluated by invtro agar diffusion and microbroth dilution assay | ChEMBL. | 15978808 |
MIC (functional) | = 2 ug ml-1 | Minimum inhibitory concentaration against Candida albicans V-01-191 evaluated by invtro agar diffusion and microbroth dilution assay | ChEMBL. | 15978808 |
MIC (functional) | = 4 ug ml-1 | Minimum inhibitory concentaration against Candida krusei ATCC6528 evaluated by invtro agar diffusion and microbroth dilution assay | ChEMBL. | 15978808 |
MIC (functional) | = 8 ug ml-1 | Minimum inhibitory concentaration against Candida krusei 1766-1 evaluated by invtro agar diffusion and microbroth dilution assay | ChEMBL. | 15978808 |
MIC (functional) | = 16 ug ml-1 | Minimum inhibitory concentaration against Aspergillus fumigatus LSI-11 evaluated by invtro agar diffusion and microbroth dilution assay | ChEMBL. | 15978808 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.